PubRank

Cynthia B Peterson

Author PubWeight™ 20.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Studying multiprotein complexes by multisignal sedimentation velocity analytical ultracentrifugation. Proc Natl Acad Sci U S A 2004 2.74
2 Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol 2011 1.17
3 A mechanism for assembly of complexes of vitronectin and plasminogen activator inhibitor-1 from sedimentation velocity analysis. J Biol Chem 2005 0.94
4 Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen. J Biol Chem 2001 0.94
5 A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity. J Biol Chem 2008 0.93
6 Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris. Protein Sci 2007 0.91
7 A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. Biochemistry 2005 0.90
8 Characterization of a site on PAI-1 that binds to vitronectin outside of the somatomedin B domain. J Biol Chem 2008 0.89
9 Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways. Am J Respir Cell Mol Biol 2012 0.88
10 The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migration. J Biol Chem 2004 0.88
11 Inhibition of neutrophil apoptosis by PAI-1. Am J Physiol Lung Cell Mol Physiol 2011 0.87
12 Plasminogen activator inhibitor type 1 promotes the self-association of vitronectin into complexes exhibiting altered incorporation into the extracellular matrix. J Biol Chem 2002 0.86
13 Sml1p is a dimer in solution: characterization of denaturation and renaturation of recombinant Sml1p. Biochemistry 2004 0.85
14 Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability. J Biol Chem 2011 0.84
15 Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition. Protein Sci 2011 0.84
16 Tissue-type plasminogen activator-plasmin-BDNF modulate glutamate-induced phase-shifts of the mouse suprachiasmatic circadian clock in vitro. Eur J Neurosci 2009 0.83
17 Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes. Protein Sci 2011 0.83
18 Activation of the zymogen to urokinase-type plasminogen activator is associated with increased interdomain flexibility. J Mol Biol 2011 0.83
19 Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages. J Immunol 2013 0.81
20 Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements. Biochemistry 2009 0.80
21 Assignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasma. J Biol Chem 2004 0.79
22 Thermodynamic characterization of a thermostable antibiotic resistance enzyme, the aminoglycoside nucleotidyltransferase (4'). Biochemistry 2012 0.78
23 Correction to Thermodynamic Characterization of a Thermostable Antibiotic Resistance Enzyme, the Aminoglycoside Nucleotidyltransferase (4'). Biochemistry 2015 0.75